These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Paclitaxel, carboplatin, 5-fluorouracil, and radiation for locally advanced esophageal cancer: phase II results of preliminary pharmacologic and molecular efforts to mitigate toxicity and predict outcomes: North Central Cancer Treatment Group (N0044). Jatoi A; Martenson JA; Foster NR; McLeod HL; Lair BS; Nichols F; Tschetter LK; Moore DF; Fitch TR; Alberts SR; Am J Clin Oncol; 2007 Oct; 30(5):507-13. PubMed ID: 17921712 [TBL] [Abstract][Full Text] [Related]
29. [Salvage surgery after definitive chemoradiation for esophageal carcinoma]. Hokamura N; Tachimori Y Nihon Geka Gakkai Zasshi; 2008 Jan; 109(1):31-5. PubMed ID: 18320808 [TBL] [Abstract][Full Text] [Related]
30. Salvage lung resection after definitive radiation (>59 Gy) for non-small cell lung cancer: surgical and oncologic outcomes. Bauman JE; Mulligan MS; Martins RG; Kurland BF; Eaton KD; Wood DE Ann Thorac Surg; 2008 Nov; 86(5):1632-8; discussion 1638-9. PubMed ID: 19049763 [TBL] [Abstract][Full Text] [Related]
31. Chemoradiation: A Superior Alternative for the Primary Management of Esophageal Carcinoma. Coia LR Semin Radiat Oncol; 1994 Jul; 4(3):157-164. PubMed ID: 10717103 [TBL] [Abstract][Full Text] [Related]
32. Comparison of outcomes for patients with unresectable, locally advanced non-small-cell lung cancer treated with induction chemotherapy followed by concurrent chemoradiation vs. concurrent chemoradiation alone. Huang EH; Liao Z; Cox JD; Guerrero TM; Chang JY; Jeter M; Borghero Y; Wei X; Fossella F; Herbst RS; Blumenschein GR; Moran C; Allen PK; Komaki R Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):779-85. PubMed ID: 17418967 [TBL] [Abstract][Full Text] [Related]
33. Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm. Pennathur A; Luketich JD; Landreneau RJ; Ward J; Christie NA; Gibson MK; Schuchert M; Cooper K; Land SR; Belani CP Ann Thorac Surg; 2008 Jun; 85(6):1930-6; discussion 1936-7. PubMed ID: 18498797 [TBL] [Abstract][Full Text] [Related]
34. Multimodality therapy for the curative treatment of cancer of the esophagus and gastroesophageal junction. Ku GY; Ilson DH Expert Rev Anticancer Ther; 2008 Dec; 8(12):1953-64. PubMed ID: 19046115 [TBL] [Abstract][Full Text] [Related]
35. [A clinical study of esophagectomy after chemo-radiation therapy for advanced esophageal carcinoma]. Takeda S; Tokuno K; Nishimura T; Yoshino S; Oka M Gan To Kagaku Ryoho; 2007 Nov; 34(12):1982-4. PubMed ID: 18219872 [TBL] [Abstract][Full Text] [Related]
36. Evidence-based radiation oncology in head and neck squamous cell carcinoma. Corvò R Radiother Oncol; 2007 Oct; 85(1):156-70. PubMed ID: 17482300 [TBL] [Abstract][Full Text] [Related]
37. Accuracy of pathologic examination in detection of complete response after chemoradiation for esophageal cancer. Chang EY; Smith CA; Corless CL; Thomas CR; Hunter JG; Jobe BA Am J Surg; 2007 May; 193(5):614-7; discussion 617. PubMed ID: 17434367 [TBL] [Abstract][Full Text] [Related]
38. Esophageal cancer. A prospective phase II study of concomitant-boost external-beam chemoradiation with a top-up endoluminal boost. Brunner TB; Rupp A; Melzner W; Grabenbauer GG; Sauer R Strahlenther Onkol; 2008 Jan; 184(1):15-22. PubMed ID: 18188518 [TBL] [Abstract][Full Text] [Related]
39. Systemic treatment for oesophageal cancer. van Meerten E; van der Gaast A Eur J Cancer; 2005 Mar; 41(5):664-72. PubMed ID: 15763640 [TBL] [Abstract][Full Text] [Related]
40. Outcomes of definitive chemoradiation in patients with esophageal cancer. Mikhail S; Wei L; Salem ME; Bekaii-Saab T Dis Esophagus; 2017 Feb; 30(2):1-7. PubMed ID: 27868290 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]